Mitral Valve Prolapse Treatment Springfield Lakes: Expert Heart Valve Care 2025

Experiencing heart palpitations or unusual heart sounds? Mitral Valve Prolapse (MVP) affects 2-3% of the population and is the most common heart valve abnormality. While often benign, proper evaluation and management ensure optimal heart health and peace of mind.

Understanding Mitral Valve Prolapse

Mitral Valve Prolapse occurs when one or both leaflets of the mitral valve bulge back into the left atrium during heart contraction, sometimes allowing blood to leak backward (mitral regurgitation).

Types of MVP

Type	Characteristics	Prevalence	Management
Primary MVP	Degenerative valve disease	2-3% population	Monitor, treat symptoms
Secondary MVP	Due to other heart conditions	Variable	Treat underlying cause
MVP with regurgitation	Blood leaks backward	15-20% of MVP cases	May need intervention
MVP without regurgitation	No blood leak	80-85% of MVP cases	Usually benign

Pathophysiology

Myxomatous degeneration – valve tissue becomes thick and floppy
Collagen abnormalities – weakened valve structure
Chordae tendineae elongation – supporting structures stretch
Left atrial pressure changes – affects valve function
Autonomic dysfunction – associated with symptoms

Causes and Risk Factors

Genetic Factors

Family history – often runs in families
Connective tissue disorders – Marfan syndrome, Ehlers-Danlos
Gender – more common in women (2:1 ratio)
Age – often diagnosed in young adulthood

Associated Conditions

Connective tissue disorders – affect valve structure
Autoimmune diseases – can affect heart valves
Thyroid disorders – hyperthyroidism association
Chest wall deformities – pectus excavatum
Low body weight – thin body habitus

Symptoms and Clinical Presentation

Common Symptoms

Palpitations – awareness of heartbeat (60-70%)
Chest pain – atypical, sharp or stabbing (40-60%)
Fatigue – exercise intolerance (30-50%)
Shortness of breath – especially with exertion (20-40%)
Dizziness – lightheadedness (15-30%)

Physical Examination

Mid-systolic click – characteristic sound
Late systolic murmur – if regurgitation present
Variable intensity – changes with position/maneuvers
Blood pressure – usually normal
Heart rate – may be irregular

Asymptomatic Presentation

Incidental finding – routine examination or imaging
Normal exercise tolerance – no functional limitation
No palpitations – regular heart rhythm sensation
Benign course – excellent prognosis

Diagnosis and Assessment

Echocardiography

Gold standard – definitive diagnosis
2D and Doppler – assess valve structure and function
Severity grading – mild, moderate, severe regurgitation
Left heart dimensions – chamber size assessment
Exercise echo – if symptoms with exertion

Physical Examination Maneuvers

Standing/squatting – changes click timing
Valsalva maneuver – earlier click and longer murmur
Handgrip – later click and shorter murmur
Leg raise – changes preload and click timing

Additional Testing

ECG – usually normal, may show arrhythmias
Holter monitor – if palpitations or syncope
Exercise stress test – assess functional capacity
Cardiac MRI – if echo images suboptimal
Blood tests – thyroid function, complete blood count

Treatment and Management

Asymptomatic MVP

Regular monitoring – annual clinical assessment
Lifestyle counseling – reassurance about benign nature
Exercise – no restrictions for most patients
Endocarditis prophylaxis – not routinely recommended
Pregnancy – generally well tolerated

Symptomatic Management

Beta-Blockers:

Indications – palpitations, chest pain, anxiety
Examples – metoprolol, atenolol
Benefits – reduce heart rate and symptoms
Dosing – start low, titrate as needed

Magnesium Supplementation:

Evidence – some benefit for symptoms
Dose – 400-800mg daily
Side effects – diarrhea, nausea
Duration – 3-6 month trial

Severe Mitral Regurgitation

Surgical repair – preferred over replacement
Timing – before left heart enlargement
Techniques – valve repair with ring annuloplasty
Outcomes – excellent long-term results
Recovery – 4-6 weeks typical

Lifestyle Management

Exercise Recommendations

Most patients – no exercise restrictions
Competitive sports – allowed if no significant regurgitation
High-intensity exercise – generally safe
Regular activity – improves cardiovascular fitness
Avoid deconditioning – maintain active lifestyle

Dietary Considerations

Caffeine – may worsen palpitations in some
Alcohol – moderate consumption
Magnesium-rich foods – nuts, leafy greens, whole grains
Hydration – maintain adequate fluid intake
Weight management – healthy BMI

Stress Management

Relaxation techniques – deep breathing, meditation
Regular sleep – 7-9 hours nightly
Stress reduction – yoga, mindfulness
Anxiety management – counseling if needed
Support groups – connect with others

Complications and Prognosis

Potential Complications

Progressive mitral regurgitation – 5-10% develop severe MR
Atrial fibrillation – increased risk with severe MR
Endocarditis – rare, higher risk with regurgitation
Sudden cardiac death – extremely rare
Heart failure – only with severe regurgitation

Long-term Prognosis

Excellent for most – normal life expectancy
Symptoms often improve – with age and lifestyle changes
Progression rare – most remain stable
Quality of life – generally excellent
Pregnancy outcomes – typically normal

Follow-up Schedule

Asymptomatic – every 3-5 years
Mild symptoms – annually
Moderate regurgitation – every 1-2 years
Severe regurgitation – every 6-12 months
Symptom changes – prompt evaluation

Special Populations

Pregnancy and MVP

Generally safe – excellent maternal and fetal outcomes
Hemodynamic changes – may improve prolapse
Delivery – vaginal delivery usually preferred
Monitoring – increased if significant regurgitation
Medications – adjust as needed during pregnancy

Athletes with MVP

Participation guidelines – based on regurgitation severity
No restrictions – for mild or no regurgitation
Activity modification – if severe regurgitation present
Regular screening – annual evaluations
Sudden death risk – extremely low

Elderly Patients

Age-related changes – may worsen prolapse
Comorbidities – consider other heart conditions
Medication interactions – careful drug selection
Functional assessment – maintain independence
Quality of life – focus on symptom management

Take Action: MVP Care

Don’t let mitral valve prolapse symptoms affect your quality of life. Health Hub Springfield Lakes provides comprehensive heart valve evaluation and management.

Book Your Heart Valve Assessment

Online booking: Available 24/7 at healthhubspringfieldlakes.com.au/
Phone booking: Call +61 7 3778 4888
Same-day consultation: Available for urgent concerns
Comprehensive evaluation: Expert cardiac assessment

Address: 18 Springfield Lakes Blvd, Springfield Lakes QLD 4300
Your trusted partner for mitral valve prolapse care and heart health.

Medical References

Delling FN, Vasan RS. Epidemiology and pathophysiology of mitral valve prolapse: new insights into disease progression, genetics, and molecular basis. Circulation. 2014;129(21):2158-2170.
Therapeutic Guidelines Limited. Cardiovascular: Mitral valve prolapse. In: eTG complete. Melbourne: Therapeutic Guidelines Limited; 2023.
Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease. Circulation. 2021;143(5):e72-e227.
Australian Government Department of Health. Guidelines for the Prevention of Endocarditis. Canberra: Commonwealth of Australia; 2022.
Freed LA, Levy D, Levine RA, et al. Prevalence and clinical outcome of mitral-valve prolapse. N Engl J Med. 1999;341(1):1-7.
Playford D, Strange G, Celermajer DS, et al. Diastolic dysfunction and mortality in 436 360 men and women: the National Echo Database Australia (NEDA). Eur Heart J Cardiovasc Imaging. 2021;22(5):505-515.
National Heart Foundation of Australia. Guidelines for the echocardiographic assessment of valve disease. Melbourne: National Heart Foundation of Australia; 2021.
Levine RA, Hagége AA, Judge DP, et al. Mitral valve disease–morphology and mechanisms. Nat Rev Cardiol. 2015;12(12):689-710.
Royal Australian College of General Practitioners. Management of valvular heart disease in general practice. Melbourne: RACGP; 2020.
Boudoulas KD, Boudoulas H. Mitral valve prolapse: the specific disease, syndrome, or both. Am J Med. 2013;126(12):1069-1076.

Medical Disclaimer: This information is for educational purposes and does not replace professional medical advice. If you’re experiencing heart palpitations or chest pain, consult a healthcare professional promptly. Health Hub Springfield Lake’s medical team provides comprehensive mitral valve prolapse care and cardiac services.